Bifogade filer
Kurs & Likviditet
Prenumeration
Kalender
2025-02-07 | Bokslutskommuniké 2024 |
2024-10-23 | Kvartalsrapport 2024-Q3 |
2024-07-18 | Kvartalsrapport 2024-Q2 |
2024-05-16 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2024-05-15 | Årsstämma 2024 |
2024-05-14 | Kvartalsrapport 2024-Q1 |
2024-02-08 | Bokslutskommuniké 2023 |
2023-10-27 | Kvartalsrapport 2023-Q3 |
2023-07-20 | Kvartalsrapport 2023-Q2 |
2023-05-08 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2023-05-05 | Kvartalsrapport 2023-Q1 |
2023-05-05 | Årsstämma 2023 |
2023-01-26 | Bokslutskommuniké 2022 |
2022-10-28 | Kvartalsrapport 2022-Q3 |
2022-07-21 | Kvartalsrapport 2022-Q2 |
2022-05-09 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2022-05-06 | Årsstämma 2022 |
2022-05-06 | Kvartalsrapport 2022-Q1 |
2022-01-27 | Bokslutskommuniké 2021 |
2021-10-28 | Kvartalsrapport 2021-Q3 |
2021-07-29 | Kvartalsrapport 2021-Q2 |
2021-05-10 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2021-05-07 | Årsstämma 2021 |
2021-05-07 | Kvartalsrapport 2021-Q1 |
2021-01-28 | Bokslutskommuniké 2020 |
2020-10-22 | Kvartalsrapport 2020-Q3 |
2020-07-31 | Kvartalsrapport 2020-Q2 |
2020-05-11 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2020-05-08 | Årsstämma 2020 |
2020-05-06 | Kvartalsrapport 2020-Q1 |
2020-01-31 | Bokslutskommuniké 2019 |
2019-12-17 | Extra Bolagsstämma 2019 |
2019-10-25 | Kvartalsrapport 2019-Q3 |
2019-08-30 | Kvartalsrapport 2019-Q2 |
2019-05-09 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2019-05-08 | Årsstämma 2019 |
2019-05-08 | Kvartalsrapport 2019-Q1 |
2019-02-08 | Bokslutskommuniké 2018 |
2018-10-26 | Kvartalsrapport 2018-Q3 |
2018-08-17 | Kvartalsrapport 2018-Q2 |
2018-05-31 | Årsstämma 2018 |
2018-05-18 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2018-04-26 | Kvartalsrapport 2018-Q1 |
2018-01-31 | Bokslutskommuniké 2017 |
2017-10-27 | Kvartalsrapport 2017-Q3 |
2017-08-16 | Kvartalsrapport 2017-Q2 |
2017-05-02 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2017-04-28 | Kvartalsrapport 2017-Q1 |
2017-04-28 | Årsstämma 2017 |
2017-02-13 | Bokslutskommuniké 2016 |
2016-11-17 | Extra Bolagsstämma 2016 |
2016-11-14 | Kvartalsrapport 2016-Q3 |
2016-08-24 | Kvartalsrapport 2016-Q2 |
2016-05-09 | Kvartalsrapport 2016-Q1 |
2016-04-15 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2016-04-14 | Årsstämma 2016 |
2016-02-08 | Bokslutskommuniké 2015 |
2015-11-06 | Kvartalsrapport 2015-Q3 |
2015-08-14 | Kvartalsrapport 2015-Q2 |
2015-05-08 | Kvartalsrapport 2015-Q1 |
2015-04-17 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2015-04-16 | Årsstämma 2015 |
2015-01-30 | Bokslutskommuniké 2014 |
2014-11-07 | Analytiker möte 2014 |
2014-11-07 | Kvartalsrapport 2014-Q3 |
2014-08-15 | Kvartalsrapport 2014-Q2 |
2014-05-16 | Kvartalsrapport 2014-Q1 |
2014-04-17 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2014-04-16 | Årsstämma 2014 |
2014-02-17 | Bokslutskommuniké 2013 |
2013-11-28 | Kvartalsrapport 2013-Q3 |
2013-11-01 | Analytiker möte 2013 |
2013-10-30 | Extra Bolagsstämma 2013 |
2013-09-02 | 15-7 2013 |
2013-08-30 | Kvartalsrapport 2013-Q2 |
2013-06-03 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2013-05-31 | Årsstämma 2013 |
2013-05-29 | Kvartalsrapport 2013-Q1 |
2013-02-26 | Bokslutskommuniké 2012 |
2012-12-04 | Extra Bolagsstämma 2012 |
2012-11-28 | Kvartalsrapport 2012-Q3 |
2012-09-04 | Kvartalsrapport 2012-Q2 |
2012-06-04 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2012-06-01 | Årsstämma 2012 |
2012-05-24 | Kvartalsrapport 2012-Q1 |
2012-02-24 | Bokslutskommuniké 2011 |
2011-11-25 | Kvartalsrapport 2011-Q3 |
2011-08-26 | Kvartalsrapport 2011-Q2 |
2011-05-26 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2011-05-25 | Årsstämma 2011 |
2011-05-24 | Kvartalsrapport 2011-Q1 |
2011-02-11 | Bokslutskommuniké 2010 |
2010-06-02 | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2010-06-01 | Årsstämma 2010 |
2010-05-28 | Kvartalsrapport 2010-Q1 |
2009-11-27 | Kvartalsrapport 2009-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Following the mandate from the Annual General Meeting held on May 5, 2023, the Board of Directors of C-RAD AB (publ) has decided to repurchase own shares
The reason for the mandate to repurchase own shares, and the Board of Directors’ decision to utilize this mandate, is to ensure the delivery of shares in connection with C-RAD’s outstanding long-term performance share plan, 2023/2026. The repurchase of own shares will be conducted in accordance with the Nordic Main Market Rulebook for Issuers of Shares.
The repurchases will be conducted in accordance with the following conditions:
- Acquisitions may be conducted on one or more occasions until the next Annual General Meeting.
- A maximum of 88,500 class B shares may be acquired.
- Acquisitions of shares are to be conducted on Nasdaq Stockholm at a price per share within the registered share price range on each occasion, by which is meant the difference between the highest buying price and the lowest selling price.
- Payment for the shares shall be made in cash.
Reporting will be made to Nasdaq Stockholm in accordance with applicable rules.
At the date of issue of this press release, the total number of C-RAD shares was 862 887 class A shares and 32 904 048 class B shares. C-RAD does not hold any own shares at the time of this press release.
For further information:
Cecilia de Leeuw, CEO, +46 (0)795 85 66 77, investors@c-rad.com
Christoffer Herou, CFO, +46 (0)725 82 86 16, investors@c-rad.com
About C-RAD
C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.
C-RAD. Inspiring excellence in cancer treatment.
C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit http://www.c-rad.com
This information is information that C-Rad is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-07-19 15:25 CEST.